当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Alexis Woodward
Diabetic renal disease, also known as diabetic nephropathy, is a progressive kidney condition that arises as a complication of diabetes mellitus. This abstract provides an overview of the study of diabetic renal disease, including its pathogenesis, risk factors, diagnosis, and management strategies. The pathogenesis of diabetic nephropathy involves multiple mechanisms, including chronic hyperglycemia, oxidative stress, inflammation, and activation of the renin-angiotensin-aldosterone system. Several risk factors, such as poor glycemic control, hypertension, and genetic predisposition, contribute to the development and progression of the disease. Diagnosis involves monitoring urinary albumin excretion, blood pressure, and renal function. Management strategies focus on lifestyle modifications, pharmacological interventions, and control of cardiovascular risk factors. Emerging therapies, including targeted agents and regenerative medicine approaches, offer potential avenues for future treatments. Understanding the complexities of diabetic renal disease is crucial for early detection, intervention, and improving outcomes for affected individuals.